Cidara Therapeutics Inc

CDTX

Get informed when a big investor buys or sells

Market Cap$5.61B

Close$

Compare to Similar Companies

	P/E Ratio	Dividends	Return on Equity	Price-to-Sales	Debt-to-Equity
Cidara Therapeutics Inc	-18.6	-	-38%	-	-

$28.08

Current Fair Value

87.3% downside

Overvalued by 87.3% based on the discounted cash flow analysis.

Share Statistics

Market cap	$5.61 Billion
Enterprise Value	$5.32 Billion
Dividend Yield	$- (-)
Earnings per Share	$-26.75
Beta	1.53
Outstanding Shares	15,547,403

Return

Return on Equity	-37.65%
Return on Assets	-30.66%
Return on Invested Capital	-46.24%

Valuation & Multiples

P/E Ratio	-18.63
PEG	-4.28
Price to Sales	-
Price to Book Ratio	8.2
Enterprise Value to Revenue	-
Enterprise Value to EBIT	-27.22
Enterprise Value to Net Income	-34
Total Debt to Enterprise	0
Debt to Equity	0

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date

November 6, 2025

EPS Estimate

$-1.34

Average shareholder expectation

Revenue Estimate

Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio	0.5785▼ 85.56%
Total Calls	2,126,749▲ 343.95%
Total Puts	1,230,300▲ 79.08%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %	214.23%▲ 5.28%
Total Invested	$7.35B▲ 136.45%
Investors Holding	280▲ 101.00%

ESG Score